Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Therapy of human papillomavirus-related disease.

Stern PL, van der Burg SH, Hampson IN, Broker TR, Fiander A, Lacey CJ, Kitchener HC, Einstein MH.

Vaccine. 2012 Nov 20;30 Suppl 5:F71-82. doi: 10.1016/j.vaccine.2012.05.091. Review.

2.

Chapter 17: Genital human papillomavirus infections--current and prospective therapies.

Stanley M.

J Natl Cancer Inst Monogr. 2003;(31):117-24. Review.

PMID:
12807955
3.

Updating the natural history of human papillomavirus and anogenital cancers.

Moscicki AB, Schiffman M, Burchell A, Albero G, Giuliano AR, Goodman MT, Kjaer SK, Palefsky J.

Vaccine. 2012 Nov 20;30 Suppl 5:F24-33. doi: 10.1016/j.vaccine.2012.05.089. Review.

4.

A review of clinical trials of human papillomavirus prophylactic vaccines.

Schiller JT, Castellsagué X, Garland SM.

Vaccine. 2012 Nov 20;30 Suppl 5:F123-38. doi: 10.1016/j.vaccine.2012.04.108. Review.

6.

Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research.

Lee SJ, Yang A, Wu TC, Hung CF.

J Gynecol Oncol. 2016 Sep;27(5):e51. doi: 10.3802/jgo.2016.27.e51. Epub 2016 May 31. Review.

7.

HPV in genital cancers (at the exception of cervical cancer) and anal cancers.

de Sanjosé S, Bruni L, Alemany L.

Presse Med. 2014 Dec;43(12 Pt 2):e423-8. doi: 10.1016/j.lpm.2014.10.001. Epub 2014 Oct 30. Review.

PMID:
25455637
8.

Genital human papillomavirus infections: current and prospective therapies.

Stanley MA.

J Gen Virol. 2012 Apr;93(Pt 4):681-91. doi: 10.1099/vir.0.039677-0. Epub 2012 Feb 8. Review.

PMID:
22323530
9.

9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV.

Pitisuttithum P, Velicer C, Luxembourg A.

Expert Rev Vaccines. 2015;14(11):1405-19. doi: 10.1586/14760584.2015.1089174. Epub 2015 Sep 14. Review.

PMID:
26366475
10.

Therapeutic human papillomavirus vaccines: current clinical trials and future directions.

Hung CF, Ma B, Monie A, Tsen SW, Wu TC.

Expert Opin Biol Ther. 2008 Apr;8(4):421-39. doi: 10.1517/14712598.8.4.421 . Review.

11.

EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease.

Arbyn M, de Sanjosé S, Saraiya M, Sideri M, Palefsky J, Lacey C, Gillison M, Bruni L, Ronco G, Wentzensen N, Brotherton J, Qiao YL, Denny L, Bornstein J, Abramowitz L, Giuliano A, Tommasino M, Monsonego J.

Int J Cancer. 2012 Nov 1;131(9):1969-82. doi: 10.1002/ijc.27650. Epub 2012 Jul 2. Review.

12.

Burden of human papillomavirus infection and related diseases in Israel.

Shavit O, Roura E, Barchana M, Diaz M, Bornstein J.

Vaccine. 2013 Nov 22;31 Suppl 8:I32-41. doi: 10.1016/j.vaccine.2013.05.108. Review.

PMID:
24229717
13.

Intrabody strategies for the treatment of human papillomavirus-associated disease.

Doorbar J, Griffin H.

Expert Opin Biol Ther. 2007 May;7(5):677-89. Review.

PMID:
17477805
14.

From the monovalent to the nine-valent HPV vaccine.

Pils S, Joura EA.

Clin Microbiol Infect. 2015 Sep;21(9):827-33. doi: 10.1016/j.cmi.2015.05.001. Epub 2015 May 14. Review.

15.

An overview of early investigational drugs for the treatment of human papilloma virus infection and associated dysplasia.

Hampson L, Martin-Hirsch P, Hampson IN.

Expert Opin Investig Drugs. 2015;24(12):1529-37. doi: 10.1517/13543784.2015.1099628. Epub 2015 Oct 12. Review.

PMID:
26457651
16.

Progress in prophylactic and therapeutic vaccines for human papillomavirus infection.

Stanley MA.

Expert Rev Vaccines. 2003 Jun;2(3):381-9. Review.

PMID:
12903803
17.

[What should be known for the introduction of an HPV vaccine?].

Muñoz N, Jacquard AC.

Presse Med. 2008 Oct;37(10):1377-90. doi: 10.1016/j.lpm.2008.04.008. Epub 2008 Sep 10. Review. French.

PMID:
18786806
18.

Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials.

Rambout L, Hopkins L, Hutton B, Fergusson D.

CMAJ. 2007 Aug 28;177(5):469-79. Epub 2007 Aug 1. Review.

19.

Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia.

Lawrie TA, Nordin A, Chakrabarti M, Bryant A, Kaushik S, Pepas L.

Cochrane Database Syst Rev. 2016 Jan 5;(1):CD011837. doi: 10.1002/14651858.CD011837.pub2. Review.

PMID:
26728940
20.

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.

Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J.

Vaccine. 2012 Nov 20;30 Suppl 5:F88-99. doi: 10.1016/j.vaccine.2012.06.095. Review. Erratum in: Vaccine. 2013 Dec 16;31(52):6266.

PMID:
23199969

Supplemental Content

Support Center